1243870

Alejandro E. De La Cruz, M.D. — FEI 3031133747

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 16, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance